BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 22330255)

  • 1. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.
    Berentsen S; Tjønnfjord GE
    Blood Rev; 2012 May; 26(3):107-15. PubMed ID: 22330255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I manage cold agglutinin disease.
    Berentsen S
    Br J Haematol; 2011 May; 153(3):309-17. PubMed ID: 21385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
    Sekkach Y; Hammi S; Elqatni M; Fatihi J; Elomri N; Mekouar F; Badaoui M; Jira M; Smaali J; El Khattabi A; Amezyane T; Abouzahir A; Ghafir D
    Ann Pharm Fr; 2011 Jul; 69(4):205-8. PubMed ID: 21840439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold agglutinin-mediated autoimmune hemolytic anemia.
    Berentsen S; Randen U; Tjønnfjord GE
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):455-71. PubMed ID: 26043385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune hemolytic anemia].
    Karasawa M
    Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune hemolytic anemia].
    Berentsen S; Sundic T; Hervig T; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2226-31. PubMed ID: 19898570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.
    Berentsen S; Randen U; Vågan AM; Hjorth-Hansen H; Vik A; Dalgaard J; Jacobsen EM; Thoresen AS; Beiske K; Tjønnfjord GE
    Blood; 2010 Oct; 116(17):3180-4. PubMed ID: 20634373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.
    Berentsen S; Beiske K; Tjønnfjord GE
    Hematology; 2007 Oct; 12(5):361-70. PubMed ID: 17891600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches for the treatment of autoimmune hemolytic anemia.
    Jaime-Pérez JC; Rodríguez-Martínez M; Gómez-de-León A; Tarín-Arzaga L; Gómez-Almaguer D
    Arch Immunol Ther Exp (Warsz); 2013 Oct; 61(5):385-95. PubMed ID: 23689532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.
    Berentsen S
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):110-2. PubMed ID: 19362990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S; Koutts J; Hertzberg MS
    Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
    Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.
    Berentsen S
    Front Immunol; 2020; 11():590. PubMed ID: 32318071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cold agglutinin disease -  no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
    Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
    Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of erythrocyte destruction in autoimmune hemolytic anemia].
    Yatomi Y
    Nihon Rinsho; 1996 Sep; 54(9):2397-401. PubMed ID: 8890568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
    Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G
    Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rheumatoid arthritis and autoimmune hemolysis: B-cell depletion for remission induction in a patient with rheumatoid arthritis and cold agglutinin disease].
    Lehmann P; Hartung W; Ehrenstein B; Schölmerich J; Fleck M
    Z Rheumatol; 2010 Aug; 69(6):557-60. PubMed ID: 20213090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cold haemolytic syndrome.
    Gertz MA
    Br J Haematol; 2007 Aug; 138(4):422-9. PubMed ID: 17561970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update.
    Michel M
    Expert Rev Hematol; 2011 Dec; 4(6):607-18. PubMed ID: 22077525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.